lumbar degenerative spondylolisthesis
Conditions
Interventions
None listed
Sponsors
Institute of Science Tokyo
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Lumbar degenerative spondylolisthesis group: Female patients aged 50 to 64 years with imaging-confirmed lumbar degenerative spondylolisthesis Control group: Women aged 50 to 64 years who underwent equol testing through the Healthcare Systems service, consented to use of their results for research, had no low back pain, and no prior diagnosis of lumbar spondylolisthesis
Exclusion criteria
Exclusion criteria: Lumbar degenerative spondylolisthesis group: History of hormone therapy, equol supplement use (within 3 months), vertebral fracture or spondylolysis history, antibiotic use (within 2 weeks), heavy lifting occupation, soy allergy, severe hepatic or renal dysfunction, dialysis, rheumatoid arthritis, inflammatory spondylitis or DISH, and investigator-determined ineligibility Control group: History of lumbar spine surgery, hormone therapy, equol supplement use (within 3 months), vertebral fracture or spondylolysis history, antibiotic use (within 2 weeks), heavy lifting occupation, soy allergy, severe hepatic or renal dysfunction, dialysis, rheumatoid arthritis, inflammatory spondylitis or DISH, and investigator-determined ineligibility
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| urinary equol concentration | — |
Secondary
| Measure | Time frame |
|---|---|
| Demographic and clinical variables, including age at the time of urinary equol measurement, sex, height, weight, body mass index (BMI), medical history, medication use, parity, age at menopause, frequency of soy intake, and bone mineral density. | — |
Countries
Japan
Contacts
Public ContactMiyamoto Reina
Institute of Science Tokyo Department of Orthopaedic and Spinal Surgery, Graduate School of Medical and Dental Sciences, Instit
Outcome results
None listed